Pharma group’s turnover down by 3.3% in Romania
The sales of Hungarian pharma group Gedeon Richter in Romania dropped by 3.3% last year, reaching EUR 144 million.
The payment terms on the Romanian pharma market continued to decline, but the industry is still dominated by excessive delays, according to the Hungarian group, reports local Ziarul Financiar.
The Romanian authorities calculated a EUR 3.7 million clawback tax for Gedeon Richter in 2014. This increased by 45% compared to 2013 when the company paid EUR 2.6 million.
The distribution and retail activities in Romania last year generated 71% of the group's revenue in this segment, namely EUR 126.7 million.
Drug production brought EUR 28.8 million in 2014, down 11.1% compared to the previous year.
Gedeon Richter Romania runs a pharmaceutical plant in Targu Mures, a network of about 120 pharmacies and the distributor Pharmafarm.
editor@romania-insider.com
